Projecting the need for confirmatory biopsies in candidates for active surveillance

A newly published paper from the Memorial Sloan-Kettering Cancer Center group in New York has proposed a predictive model which might allow a high percentage of candidates for active surveillance as initial management to skip a second, confirmatory biopsy after initial diagnosis. … READ MORE –

First and second biopsies and their diagnostic accuracy

A paper by Wong et al. published in December carries the title, “Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer.” … READ MORE …

Upgrading after re-biopsy in the Sunnybrook active surveillance cohort

In another key paper to be presented at the Genitourinary Oncology Symposium in Orlando tomorrow, Klotz and his colleagues have provided data on the rate of pathological upgrading at re-biopsy in their large cohort of patients on active surveillance at the Sunnybrook Health Sciences Center in Toronto. … READ MORE …

Prostate cancer news reports: Thursday, May 28, 2009

Today’s prostate cancer news reports address:

  • A review of data on the potential for prostate cancer prevention
  • A review of appropriate strategic options for rebiopsy in patients at risk
  • Prostate cancer in men with a PSA < 2.5 ng/ml
  • The sequential use of multiple cycles of docetaxel therapy … READ MORE …